Whalesbook
How UltraTech Achieved Record Results
UltraTech Cement's strong Q4 was driven by significant volume growth. India's grey cement sales volumes increased 9.3% year-on-year, reaching 42.41 million tonnes. This volume expansion, combined with effective price management, allowed the company to achieve an all-time quarterly high in operating EBITDA of ₹5,688 crore, a 20% jump from the previous year. Operating EBITDA per tonne rose to ₹1,253, demonstrating operational efficiency. The company declared a record dividend of ₹240 per share, up from ₹77.5 the previous year. As of April 29, 2026, the stock was trading around ₹11,833.
Industry Expansion Fuels Overcapacity Fears
However, this individual success comes as the broader cement industry faces significant challenges. Analysts are watching substantial new capacity additions across the sector. Projections show an increase of 160-170 million metric tons of grinding capacity between fiscal years 2026 and 2028, a sharp rise compared to previous years. This rapid expansion is intensifying competition and could pressure future profitability.
Valuation and Competitive Pressure
The heightened competition and potential oversupply raise concerns about price wars and margin stability. While UltraTech Cement trades at a premium valuation, with a P/E ratio around 42.70x, its peers like Ambuja Cement trade at about 27.7x and Shree Cement at 51.93x. Sustaining its premium may be difficult if industry-wide price competition increases.
Risks and Outlook for Investors
Key risks include fluctuating fuel costs, a major input for cement production. UltraTech is attempting to manage this challenge by adjusting prices, as seen in early April. The company's Net Debt-to-EBITDA ratio improved to 0.94x as of March 31, 2026, a healthy level, though higher than some competitors like Ambuja Cement, which is nearly debt-free. These sector-specific concerns have led some analysts to maintain 'Hold' ratings, despite recognizing UltraTech's operational strengths.
Analyst Outlook and Future Plans
Despite these industry pressures, many analysts remain positive on UltraTech's long-term outlook, citing its market leadership and growth plans. Brokerages like Jefferies and HSBC have 'Buy' ratings with price targets near ₹14,050 and ₹14,200 respectively. Nomura suggests a target of ₹13,900, anticipating earnings surprises from better pricing. With 38 analysts covering the stock, the consensus is 'Strong Buy' with an average 12-month target of ₹13,636.79. Management plans significant investment over the next three years to boost total capacity past 240 MTPA and aims for double-digit volume growth in FY27, outpacing the industry's estimated 7-8% growth.